lack
endotheli
nitric
oxid
caus
endotheli
dysfunct
circul
monocyt
infiltr
contribut
system
atheroma
plaqu
format
arteri
territori
among
differ
inflammatori
product
macrophagederiv
foam
cell
smooth
muscl
cell
synthes
matrix
metalloproteinas
mmp
play
pivot
role
earli
plaqu
format
enlarg
found
increas
level
human
endarterectomi
advanc
atherosclerosi
togeth
signific
amount
extracellular
matrix
ecm
metalloproteinas
induc
emmprin
test
whether
absenc
may
aggrav
atherosclerosi
emmprin
activ
doubl
knockout
ko
mice
express
high
level
emmprin
carotid
plaqu
suggest
target
extracellular
matrix
degrad
may
repres
new
mechan
endotheli
prevent
atherosclerosi
base
previou
experi
use
gadoliniumenrich
paramagnet
fluoresc
micellar
nanoparticl
conjug
emmprinspecif
bind
peptid
magnet
reson
sequenc
allow
noninvas
visual
carotid
emmprin
apo
control
mice
atheroma
plaqu
significantli
reduc
taken
togeth
result
point
emmprin
new
therapeut
target
nomedi
protect
atherosclerosi
noninvas
molecular
tool
target
atherosclerosi
absenc
endotheli
vascular
endotheli
cell
becom
dysfunct
play
signific
role
pathogenesi
atherosclerosi
endotheli
dysfunct
culmin
loss
endothelialdepend
vessel
wall
relax
increas
leukocyteendotheli
vessel
wall
adhes
oxid
lowdens
lipoprotein
ldl
uptak
platelet
aggreg
proinflammatori
cytokin
express
extracellular
matrix
ecm
degrad
howev
mechan
prevent
atherosclerosi
fulli
understood
extracellular
matrix
metalloproteinas
induc
emmprin
basigin
play
pivot
role
pathogenesi
cardiac
atherothrombot
diseas
emmprin
glycoprotein
regul
mmp
express
sever
cell
type
includ
endotheli
cell
vascular
smooth
muscl
cell
monocyt
macrophag
cardiac
myocyt
activ
emmprin
requir
glycosyl
correct
protein
traffick
cell
surfac
form
oligom
bind
ligand
cyclophilin
cypa
elev
level
circul
cypa
detect
oxid
stress
hypoxia
inflamm
facilit
format
cypaemmprin
complex
onset
acut
myocardi
infarct
atherosclerosi
cypaemmprin
complex
lead
platelet
activ
adhes
thrombu
format
foam
cell
differenti
play
critic
role
plaqu
progress
vulner
therefor
target
emmprin
may
constitut
novel
therapeut
approach
promot
cardiovascular
protect
recent
use
statin
particular
atorvastatin
effect
reduc
plaqu
vulner
least
downregul
express
emmprin
use
antiemmprin
specif
antibodi
downsiz
atheroma
plaqu
inhibit
express
mmp
monocyt
recruit
vascular
wall
also
appli
respons
acut
myocardi
infarct
preserv
left
ventricular
function
disrupt
complex
cypaemmprin
use
specif
antibodi
target
protein
includ
emmprin
investig
uncertain
benefit
patient
reason
includ
absenc
therapeut
effect
even
antibodymedi
side
effect
henc
effici
altern
includ
smaller
bind
molecul
may
repres
promis
approach
regard
paramagnet
micel
use
target
specif
protein
present
sever
pathophysiolog
condit
includ
emmprin
noninvas
visual
molecular
magnet
reson
imag
mri
find
signific
reduct
left
ventricl
necrot
area
murin
porcin
model
acut
myocardi
infarct
previous
found
prevent
develop
atheroma
plaqu
apo
doubl
ko
atherosclerot
mice
howev
role
emmprin
endotheli
nomedi
inhibit
atherosclerosi
remain
elucid
use
paramagnet
micel
vivo
noninvas
visual
emmprin
atherosclerot
apo
doubl
null
mice
evalu
hypothesi
target
inhibit
emmprin
may
repres
new
mechan
elicit
atherosclerosi
level
emmprin
determin
immunohistochemistri
human
cross
section
carotid
endarterectomi
specimen
show
extens
atherosclerosi
shown
hematoxylineosin
masson
trichrom
stain
figur
extens
express
emmprin
detect
smooth
muscl
cell
foam
cell
emmprin
also
express
endotheli
cell
vascular
plaqu
figur
compar
level
found
healthi
control
mammari
arteri
figur
suggest
emmprin
may
contribut
extens
atheroma
plaqu
apo
doubl
null
mice
fed
week
western
diet
develop
atherosclerot
lesion
blood
glucos
content
total
cholesterol
triglycerid
content
show
signific
differ
arteri
blood
pressur
increas
null
mice
previous
report
tabl
morphometr
analysi
assay
hematoxylineosin
stain
carotid
section
oilredo
stain
full
size
carotid
longitudin
section
reveal
carotid
lesion
size
apo
vs
p
number
apo
vs
p
significantli
increas
knockout
ko
mice
figur
b
suggest
measur
might
correl
extens
carotid
atherosclerosi
howev
sinc
free
radic
ga
molecul
nodownstream
target
use
instead
quantif
apo
doubl
null
mice
fed
week
western
diet
develop
atherosclerot
lesion
blood
glucos
content
total
cholesterol
triglycerid
content
show
signific
differ
arteri
blood
pressur
increas
null
mice
previous
report
tabl
morphometr
analysi
assay
hematoxylineosin
stain
carotid
section
oilredo
stain
full
size
carotid
longitudin
section
reveal
carotid
lesion
size
apo
vs
p
number
apo
vs
p
significantli
increas
knockout
ko
mice
figur
b
suggest
measur
might
correl
extens
carotid
atherosclerosi
howev
sinc
free
radic
ga
molecul
nodownstream
target
use
instead
quantif
other
found
express
emmprin
part
inflammatori
respons
associ
cardiovascular
diseas
includ
abdomin
aortic
aneurysm
cardiac
ischemiareperfus
injuri
test
whether
emmprin
also
express
carotid
atherosclerot
plaqu
found
extens
coloc
emmprin
posit
infiltr
macrophag
doubl
ko
mice
compar
anim
figur
indic
emmprin
target
carotid
inflamm
atherosclerosi
previous
found
nanoparticl
harbor
emmprinbind
peptid
figur
specif
target
emmprin
acut
murin
porcin
myocardi
infarct
test
potenti
use
carotid
atherosclerosi
mice
fed
western
diet
week
intraven
inject
mgkgday
salin
carotid
section
reveal
strong
coloc
intraplaqu
emmprin
detect
incub
specif
antiemmprin
antibodi
fitc
green
exogen
inject
conjug
rhodamin
red
detect
confoc
microscopi
merg
yellow
figur
elucid
contribut
protect
atherosclerosi
analyz
level
indic
emmprin
activ
carotid
arteri
found
mice
inject
mgkgday
level
significantli
reduc
compar
found
mice
inject
nanoparticl
np
control
nanoparticl
lack
control
np
vs
figur
taken
togeth
result
show
nanoparticl
may
target
atherosclerosi
vivo
reduc
downstream
express
other
found
express
emmprin
part
inflammatori
respons
associ
cardiovascular
diseas
includ
abdomin
aortic
aneurysm
cardiac
ischemiareperfus
injuri
test
whether
emmprin
also
express
carotid
atherosclerot
plaqu
found
extens
coloc
emmprin
posit
infiltr
macrophag
doubl
ko
mice
compar
anim
figur
indic
emmprin
target
carotid
inflamm
atherosclerosi
previous
found
nanoparticl
harbor
emmprinbind
peptid
figur
specif
target
emmprin
acut
murin
porcin
myocardi
infarct
test
potenti
use
carotid
atherosclerosi
mice
fed
western
diet
week
intraven
inject
mgkgday
salin
carotid
section
reveal
strong
coloc
intraplaqu
emmprin
detect
incub
specif
antiemmprin
antibodi
fitc
green
exogen
inject
conjug
rhodamin
red
detect
confoc
microscopi
merg
yellow
figur
elucid
contribut
protect
atherosclerosi
analyz
level
indic
emmprin
activ
carotid
arteri
found
mice
inject
mgkgday
level
significantli
reduc
compar
found
mice
inject
nanoparticl
np
control
nanoparticl
lack
control
np
vs
figur
taken
togeth
result
show
nanoparticl
may
target
atherosclerosi
vivo
reduc
downstream
express
intraven
inject
mgkgday
control
np
apo
ko
mice
fed
western
diet
week
accord
level
emmprin
exvivo
detect
confoc
microscopi
figur
mri
sequenc
reveal
gadolinium
enhanc
carotid
wall
atheroma
plaqu
inject
doubl
ko
compar
singl
apo
null
mice
figur
similar
result
detect
carotid
angiographi
perform
specimen
figur
linear
regress
analysi
detect
posit
correl
uptak
ex
vivo
measur
emmprin
carotid
section
mice
figur
r
p
suggest
nanoparticl
may
repres
new
tool
non
intraven
inject
mgkgday
control
np
apo
ko
mice
fed
western
diet
week
accord
level
emmprin
exvivo
detect
confoc
microscopi
figur
mri
sequenc
reveal
gadolinium
enhanc
carotid
wall
atheroma
plaqu
inject
doubl
ko
compar
singl
apo
null
mice
figur
similar
result
detect
carotid
angiographi
perform
specimen
figur
linear
regress
analysi
detect
posit
correl
uptak
ex
vivo
measur
emmprin
carotid
section
mice
figur
r
p
suggest
nanoparticl
may
repres
new
tool
noninvas
target
atherosclerosi
vivo
efficaci
noninvas
method
plaqu
detect
also
assess
aortic
arch
ko
mice
intraven
inject
mgkgday
control
np
figur
show
effect
prevent
carotid
atherosclerosi
mice
lack
demonstr
extens
atherosclerot
lesion
compar
express
mice
fed
high
cholesterol
diet
number
size
mice
lack
show
increas
level
matrix
metalloproteinas
togeth
extracellular
matrix
metalloproteinas
induc
emmprin
smooth
muscl
cell
infiltr
macrophag
vascular
endotheli
cell
intraplaqu
vessel
use
nanoparticl
target
express
emmprin
atherosclerosi
find
specif
plaqu
coloc
emmprinexpress
cell
magnet
reson
imag
taken
mice
fed
high
cholesterol
diet
reveal
signal
enhanc
carotid
inject
rather
control
np
noninvas
imag
detect
emmprin
time
increas
vessel
wall
atheroma
plaqu
atherosclerot
null
mice
respect
singl
apo
defici
anim
suggest
nanoparticl
may
repres
new
tool
noninvas
vivo
target
atherosclerosi
other
found
emmprin
express
sever
inflammatori
condit
includ
abdomin
aortic
aneurysm
acut
myocardi
infarct
atherosclerosi
besid
inflammatori
macrophag
also
found
emmprin
present
smooth
muscl
cell
endotheli
cell
intraplaqu
vascular
human
carotid
atherosclerosi
emmprin
glycosyl
traffick
golgi
surfac
membran
key
step
emmprin
enzymat
activ
bind
differ
protein
absolut
requir
state
role
complex
cypaemmprin
pathogenesi
cardiovascular
diseas
addit
emmprin
bind
protein
proper
fold
activ
like
complex
regul
emmprin
activ
case
cyclophilin
drive
emmprin
golgi
plasma
membran
bind
betasecreatas
compon
relev
alzheim
diseas
bind
caveolin
show
effect
prevent
carotid
atherosclerosi
mice
lack
demonstr
extens
atherosclerot
lesion
compar
express
mice
fed
high
cholesterol
diet
number
size
mice
lack
show
increas
level
matrix
metalloproteinas
togeth
extracellular
matrix
metalloproteinas
induc
emmprin
smooth
muscl
cell
infiltr
macrophag
vascular
endotheli
cell
intraplaqu
vessel
use
nanoparticl
target
express
emmprin
atherosclerosi
find
specif
plaqu
coloc
emmprinexpress
cell
magnet
reson
imag
taken
mice
fed
high
cholesterol
diet
reveal
signal
enhanc
carotid
inject
rather
control
np
noninvas
imag
detect
emmprin
time
increas
vessel
wall
atheroma
plaqu
atherosclerot
null
mice
respect
singl
apo
defici
anim
suggest
nanoparticl
may
repres
new
tool
noninvas
vivo
target
atherosclerosi
other
found
emmprin
express
sever
inflammatori
condit
includ
abdomin
aortic
aneurysm
acut
myocardi
infarct
atherosclerosi
besid
inflammatori
macrophag
also
found
emmprin
present
smooth
muscl
cell
endotheli
cell
intraplaqu
vascular
human
carotid
atherosclerosi
emmprin
glycosyl
traffick
golgi
surfac
membran
key
step
emmprin
enzymat
activ
bind
differ
protein
absolut
requir
state
role
complex
cypaemmprin
pathogenesi
cardiovascular
diseas
addit
emmprin
bind
protein
proper
fold
activ
like
complex
regul
emmprin
activ
case
cyclophilin
drive
emmprin
golgi
plasma
membran
bind
betasecreatas
compon
relev
alzheim
diseas
bind
caveolin
complex
heart
prevent
emmprin
glycosyl
step
requir
emmprin
selfaggreg
downstreammedi
express
mmp
henc
factor
promot
disrupt
certain
complex
may
power
induceinhibit
emmprin
context
differ
pathophysiolog
condit
case
recent
find
disrupt
complex
small
molecul
term
acriflavin
inhibit
hypox
respons
prolifer
tumor
progress
glioblastoma
cell
cardioprotect
effect
acut
myocardi
infarct
complex
emmprin
stabil
thu
prevent
emmprin
glycosyl
previous
found
prevent
aortic
atherosclerosi
mice
least
regul
express
yet
unknown
mechan
show
absenc
level
emmprin
posit
intraplaqu
macrophag
signific
correl
extens
plaqu
burden
compar
express
atherosclerot
mice
suggest
may
prevent
mmpmediat
atherosclerosi
emmprin
inhibit
evidenc
cardiac
myocyt
show
inhibit
emmprin
mrna
express
repress
promot
region
absenc
increas
transcript
express
emmprin
may
allow
accumul
high
glycosyl
form
emmprin
help
explain
level
mmp
human
murin
atherosclerosi
addit
recent
find
nomedi
emmprin
snitrosyl
may
also
contribut
inhibit
mmpmediat
atherosclerosi
strategi
focus
use
emmprin
therapeut
target
atherosclerosi
acut
myocardi
infarct
differ
type
cancer
implement
preclin
model
diseas
atherosclerosi
emmprin
play
key
role
foam
cell
plaqu
format
found
play
pivot
role
control
emmprindepend
carotid
atherosclerosi
use
antibodymedi
target
protein
evalu
howev
human
studi
undertaken
reason
includ
immun
cross
reactiv
antibodymedi
side
effect
lack
therapeut
improv
avoid
undesir
side
effect
other
use
smaller
bind
molecul
target
interest
includ
specif
bind
peptid
knowledg
pioneer
use
specif
emmprinbind
peptid
preclin
anim
model
acut
myocardi
infarct
sinc
test
cell
cell
peripher
blood
monocyt
cell
cultur
paramagnet
micel
use
target
specif
molecul
potenti
interest
biomark
diseas
bound
specif
emmprin
bind
peptid
gadoliniumbas
paramagnet
micel
form
nanoparticl
name
permit
us
noninvas
visual
emmprin
mri
onset
progress
acut
myocardi
infarct
target
express
emmprin
carotid
atherosclerosi
provid
evid
use
noninvas
strategi
theranost
potenti
narrow
specif
molecul
involv
atherosclerosi
like
emmprin
may
signific
impact
come
futur
improv
precis
diagnost
manag
coronari
arteri
diseas
includ
coronari
atheroma
plaqu
vulner
acut
coronari
syndrom
promis
implic
futur
clinic
practic
focus
prevent
diagnost
follow
progress
diseas
conclus
point
new
mechan
endotheli
prevent
carotid
atherosclerosi
inhibit
emmprinmedi
mmp
format
macrophag
smooth
muscl
cell
endotheli
cell
intraplaqu
vessel
provid
new
therapeut
tool
noninvas
visual
target
plaqu
format
develop
limit
studi
may
includ
use
male
younger
mammari
arteri
control
human
analysi
carotid
endarterectomi
anim
model
sinc
human
mous
arteri
atheroma
plaqu
composit
differ
therefor
studi
porcin
model
carotid
atherosclerosi
crucial
futur
test
human
histolog
reagent
secondari
antibodi
sigma
st
loui
mo
usa
dab
substrat
dako
carpinteria
ca
usa
ecl
ge
life
scienc
barcelona
spain
antiemmprin
primari
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
usa
nanoparticl
compon
form
avanti
polar
lipid
labclin
barcelona
spain
research
perform
accord
rule
declar
helsinki
revis
studi
approv
ethic
committe
univers
francisco
de
vitoria
spain
written
consent
achiev
subject
studi
angiographi
doppler
ultrasound
use
select
carotid
endarterectomi
patient
men
mean
age
year
women
mean
age
year
mammari
arteri
obtain
surgic
residu
male
patient
mean
age
year
use
healthi
control
anim
research
perform
accord
guid
care
use
laboratori
anim
us
nation
institut
health
nih
public
revis
apo
knockout
anim
acquir
jackson
laboratori
bar
harbor
usa
gener
doubl
knockout
genotyp
fourweekold
male
mice
fed
western
diet
harland
tekla
week
mice
use
experiment
overnight
fast
blood
sampl
taken
fom
mice
fed
western
diet
total
cholestrol
triglicerid
glucos
level
measur
biochemistri
facil
hospit
arteri
blood
pressur
measur
conciou
mice
prewarm
c
use
tailcuff
sphyngomanomet
le
letica
scientif
instrument
prevent
stress
anim
train
consecut
day
measur
lesion
quantit
carotid
stain
oilredo
previous
describ
brief
carotid
longitudin
slice
incub
oilredo
solut
min
wash
time
salin
buffer
remov
unbound
reagent
carotid
scan
percentag
plaqu
area
plaqu
number
analyz
doubl
blind
fashion
use
imagej
imag
analysi
softwar
nation
institut
health
bethesda
usa
confoc
microscopi
perform
specif
antiemmprin
primari
antibodi
describ
paraffin
embed
carotid
section
incub
primari
antibodi
wash
pb
buffer
incub
appropri
secondari
antibodi
section
mount
hoechst
contain
media
evalu
leica
confoc
microscopi
amino
acid
sequenc
peptid
yklpghhhhyrp
paramagnet
nanoparticl
synthes
lipid
film
hydrat
procedur
describ
brief
rotari
evapor
rhodaminep
gddtpabi
gddtpabsa
methoxi
polyethylen
glycol
use
gener
lipid
film
molar
ratio
peptid
conjug
maleimid
molar
ratio
micel
peptid
highperform
liquid
chromatographi
hplc
use
estim
number
conjug
per
nanoparticl
magnet
reson
mr
assay
develop
tesla
bruker
biospec
bruker
biospin
ettlingen
germani
cm
gradient
achiev
top
gradient
mtm
describ
axial
sagitt
coron
imag
acquir
use
weight
spin
echo
sequenc
respiratori
gate
spin
echo
imag
taken
ms
repetit
time
angiographi
perform
use
gradient
echo
includ
flow
compens
imag
sequenc
acquisit
matrix
size
fov
cm
includ
slice
data
interpol
obtain
matrix
fov
cm
mip
algorithm
use
data
gener
dimension
view
signal
nois
ratio
snr
particular
region
interest
roi
defin
follow
ner
snrca
snrt
post
inject
snrca
snrt
pre
inject
snrca
snrt
pre
inject
unless
otherwis
specifi
data
present
mean
sd
statist
signific
determin
student
test
two
side
unpair
differ
consid
statist
signific
p
